Vermont · 64405

Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve in Vermont

Vermont Medicare Avg
$57.26
2% above national avg
National Medicare Avg
$55.96
All states combined
Billed Charge (VT)
$333.21
What providers submit
Est. Commercial (VT)
$171.49
National avg: $164.22
Est. Cash / Self-Pay (VT)
$150.09
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

152
Services in VT
23
Providers
N/A
Min Payment
N/A
Max Payment

Vermont Pricing in Context

In Vermont, CPT code 64405 (Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve) carries an average Medicare payment of $57.26 — 2% above the national benchmark of $55.96. 23 providers across the state submitted claims for this procedure in 2023, performing 152 total services. Individual payments in VT ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Vermont is $333.21, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Vermont sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Nervous System Surgery procedures, the estimated commercial insurance price in Vermont lands near $171.49, with self-pay cash prices typically around $150.09. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve cost in Vermont?

The average Medicare payment for Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve in Vermont is $57.26, which is 2% above the national average of $55.96. Providers in VT typically bill $333.21 for this procedure.

What does Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve cost with insurance in Vermont?

With commercial insurance in Vermont, Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve costs an estimated $171.49. Without insurance, the estimated cash price is $150.09. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve in Vermont?

23 providers in Vermont billed Medicare for Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve in 2023, performing 152 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve cheaper in Vermont than the national average?

No — Injection Of Anesthetic Agent And/or Steroid Into Upper Neck And Back Of Head Nerve costs 2% above the national average in Vermont. The state average Medicare payment is $57.26 compared to $55.96 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial